Simplify Asset Management Inc. Has $6.40 Million Stock Position in CVS Health Corporation $CVS

Simplify Asset Management Inc. boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 80.8% during the third quarter, Holdings Channel.com reports. The institutional investor owned 84,926 shares of the pharmacy operator’s stock after acquiring an additional 37,960 shares during the quarter. CVS Health accounts for approximately 0.1% of Simplify Asset Management Inc.’s portfolio, making the stock its 25th largest position. Simplify Asset Management Inc.’s holdings in CVS Health were worth $6,403,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Symmetry Partners LLC increased its holdings in shares of CVS Health by 2.5% during the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock worth $439,000 after acquiring an additional 141 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the last quarter. HF Advisory Group LLC raised its position in shares of CVS Health by 2.9% in the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock valued at $393,000 after purchasing an additional 145 shares during the period. FineMark National Bank & Trust lifted its stake in shares of CVS Health by 1.7% during the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after buying an additional 157 shares during the last quarter. Finally, 1620 Investment Advisors Inc. boosted its holdings in shares of CVS Health by 6.1% during the 3rd quarter. 1620 Investment Advisors Inc. now owns 2,736 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 157 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 0.4%

CVS opened at $79.96 on Tuesday. The stock has a market capitalization of $101.50 billion, a price-to-earnings ratio of 210.41, a P/E/G ratio of 0.79 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $43.65 and a twelve month high of $85.15. The company has a 50-day simple moving average of $78.86 and a 200 day simple moving average of $73.11.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the firm earned $1.09 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Analyst Ratings Changes

CVS has been the topic of several research analyst reports. Truist Financial set a $100.00 price target on shares of CVS Health in a report on Wednesday, December 10th. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Evercore ISI boosted their price target on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 22nd. Finally, Sanford C. Bernstein boosted their target price on shares of CVS Health from $86.00 to $87.00 and gave the company a “market perform” rating in a research report on Friday, December 12th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.